SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (11965)12/2/1997 10:29:00 AM
From: Alper H.YUKSEL  Read Replies (1) | Respond to of 32384
 
> Looks like AGPH will be hit hard this morning (ask is already down to $34): Agouron and Roche to End Cancer Collaboration; Agouron to Discontinue Development of AG337 <

Henry,

With the weak status of LGND, the last thing we need would be a similar occurence with LGND, i.e. a termination of one of LGND's many partnerships or release of poor clinicals. How (un)likely would you rate something like this happening to LGND ?

Alper


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News